Alfonso Gómez de Liaño
Hospital Universitario Insular de Gran Canaria(ES)
Publications by Year
Research Areas
Bladder and Urothelial Cancer Treatments, Cancer Immunotherapy and Biomarkers, Urinary and Genital Oncology Studies, Renal cell carcinoma treatment, Prostate Cancer Treatment and Research
Most-Cited Works
- → Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial(2017)1,842 cited
- → Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial(2021)399 cited
- → Response Rate to Chemotherapy After Immune Checkpoint Inhibition in Metastatic Urothelial Cancer(2017)133 cited
- → Clinical outcome after progressing to frontline and second-line Anti–PD-1/PD-L1 in advanced urothelial cancer(2019)62 cited
- → Recent advances in neoadjuvant immunotherapy for urothelial bladder cancer: What to expect in the near future(2021)52 cited
- → The efficacy of VEGFR TKI therapy after progression on immune combination therapy in metastatic renal cell carcinoma(2018)49 cited
- → Prognostic and predictive value of plasma testosterone levels in patients receiving first-line chemotherapy for metastatic castrate-resistant prostate cancer(2014)21 cited
- → Retifanlimab in Advanced Penile Squamous Cell Carcinoma: The Phase 2 ORPHEUS Study(2024)19 cited
- → Complete response and renal cell carcinoma in the immunotherapy era: The paradox of good news(2021)18 cited
- → The continuing role of chemotherapy in the management of advanced urothelial cancer(2018)18 cited